Research Article
Residual Quantitative Flow Ratio to Estimate Post‐Percutaneous Coronary Intervention Fractional Flow Reserve
| Patient characteristics | N = 115 |
| Male gender | 89 (77%) | Age in years | 64.9 ± 9.9 | Body mass index (kg/m2) | 26.7 ± 3.8 |
| Cardiovascular risk factors | Diabetes mellitus | 18 (16%) | Hypertension | 61 (53%) | Hypercholesterolemia | 67 (58%) | Tobacco use | 11 (10%) | History of tobacco use | 58 (50%) | Family history of coronary artery disease | 49 (44%) |
| Medication | Acetylic acid | 101 (88%) | P2Y12 inhibitor | 36 (31%) | Beta-blockers | 64 (56%) | Calcium-channel blockers | 47 (41%) | Long-acting nitrates | 23 (20%) | Statins | 93 (81%) | Angiotensin-converting enzyme inhibitors | 27 (24%) | Angiotensin receptor blockers | 17 (15%) |
| Cardiac history | Prior percutaneous coronary intervention | 55 (48%) | Prior myocardial infarction | 29 (25%) |
| Symptoms | Typical angina pectoris | 57 (50%) | Atypical angina pectoris | 24 (21%) | Nonspecific chest pain | 8 (7%) | Dyspnea | 16 (14%) | Asymptomatic | 10 (9%) |
| Indication for percutaneous coronary intervention | Stable coronary artery disease | 114 (99%) | Non-ST segment elevation myocardial infarction | 1 (1%) |
|
|
Values are presented as N (%) or mean ± SD.
|